Compare Ginkgo Bioworks Holdings Inc (DNA) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Clear Secure Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while Clear Secure Inc trades at $43.43 (market cap $4.44B). The key difference: Clear Secure Inc is far larger — about 5.8× Ginkgo Bioworks Holdings Inc's market cap, and Clear Secure Inc pays a 1.33% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Clear Secure Inc for 19 Days on average.
| DNA | YOU | |
|---|---|---|
Market Cap | $763.64M | $4.44B |
Volume | 3,204,177 | 1,477,828 |
Sector | Health | Technology |
52-Week High | $15.83 | $62.36 |
52-Week Low | $5.48 | $29.61 |
Typical Hold Time | 7 Days | 19 Days |
Enterprise Value | $865.59M | $3.59B |
Dividend Yield | — | 1.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $13.00, up 13.34% today, with a bullish technical signal from moving averages. The company shows strong gross margins of 68.04% but remains unprofitable with a -219.6% net margin. Recent news includes a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnership expansions, though revenue declined to $132M in 2026.
DNA presents high risk with significant losses and cash burn, but analyst sentiment is divided with equal buy/sell ratings. Investment appeal hinges on future profitability from recent partnerships and government contracts, while current financials and negative cash flow pose substantial downside risk.
Clear Secure (YOU) trades at $43.08, up 1.17% with strong fundamentals including 27% revenue growth and expanding profitability. The stock shows mixed technical signals with bullish overall momentum but overbought RSI levels. Recent Q2 earnings beat expectations with $0.49 EPS versus $0.40 estimate, while analyst consensus targets $61.40 representing 43% upside potential.
Outlook remains positive with accelerating membership growth and new corporate partnerships driving expansion. Key risks include competitive pressure in identity verification and potential execution challenges. The stock offers growth exposure but requires monitoring of technical overbought conditions and quarterly execution against elevated expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
